Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
Indian J Lepr
;
1987 Jan-Mar; 59(1): 36-43
Article
in English
| IMSEAR
| ID: sea-54485
ABSTRACT
56 lepromatous leprosy patients with an initial average BI of 4.45 were administered once a month 600 mg of Rifampicin, 100 mg of Clofazimine on alternate days and 100 mg of Dapsone daily. None of these patients became smear negative in 2 years, and the same regimen was continued further. Two patients have become negative in 3 years and treatment has been stopped in them. The study indicates that highly bacilliferous LL/BL patients are likely to need 3 years or more of MDT for achieving bacterial negativity.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Rifampin
/
Female
/
Humans
/
Male
/
Follow-Up Studies
/
Adolescent
/
Clofazimine
/
Adult
/
Dapsone
/
Drug Therapy, Combination
Type of study:
Observational study
/
Prognostic study
/
Risk factors
Language:
English
Journal:
Indian J Lepr
Journal subject:
Tropical Medicine
Year:
1987
Type:
Article
Similar
MEDLINE
...
LILACS
LIS